Enteral vs. Oral Nutrition After Pancreatoduodenectomy
NUTRIWHI
Early Enteral vs. Oral Nutrition After Whipple Procedure: a Multicentric Randomized Controlled Trial
1 other identifier
interventional
144
2 countries
3
Brief Summary
Patients suffering from pancreas cancer as well as patients with chronic pancreatitis or requiring pancreas surgery often are in a compromised nutritional status. Nutritional support should therefore be started early during the postoperative course to prevent further malnutrition, as it is an important risk factor to develop complications. Recently, several studies have shown that early enteral nutrition (EEN) could shorten length of stay, reduce postoperative infections and mortality, and decrease costs when compared with total parenteral nutrition (TPN) in gastrointestinal cancer surgery. After pancreatoduodenectomy (PD), EEN has been shown to reduce early and late complications, infections, and readmission rates. It is nevertheless currently not clear if EEN improves the short-term outcomes after PD compared to oral nutrition. The primary objective of the study is to assess the impact of EEN on postoperative morbidity after PD, according to the Comprehensive Complication Index. Secondary objectives are to assess the impact of EEN on major postoperative complications, according to Clavien classification, specific complications, length of stay, readmission rates, quality of life, metabolic stress and nutritional response after PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2021
CompletedFirst Posted
Study publicly available on registry
September 13, 2021
CompletedStudy Start
First participant enrolled
December 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2025
CompletedApril 3, 2025
March 1, 2025
3.1 years
August 30, 2021
March 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comprehensive Complication Index
Index measuring all complications for a patient
Postoperative day 90
Secondary Outcomes (9)
Severe postoperative complications
Postoperative day 90
Specific complications after pancreatoduodenectomy
Postoperative day 90
Length of stay
Up to 90 days
Readmission
Postoperative day 90
Patients' quality of life
Preoperatively and at 30 and 90 days after the operation
- +4 more secondary outcomes
Study Arms (2)
Early enteral nutrition
EXPERIMENTALIntervention group: enteral nutrition from the first postoperative night until 50% of caloric requirements are covered by oral nutrition. Enteral nutrition will start at a flow of 250 ml/12h. If tolerated, enteral nutrition will be increased to 500 ml/12h on postoperative day 1, 750 ml/12h on postoperative day 2, and 1000 ml/12h on postoperative day 3. A hypercaloric enteral nutrition will be used (Isosource Energy Fibre or similar).
Oral nutrition
NO INTERVENTIONControl group: patients will receive standardized oral nutrition. The night after the operation, patients will be allowed to have free drinks. On postoperative day 1, they will receive bouillons, creams, yogurts, and drinks \>2 l. On postoperative day 2, they will receive a light diet. On postoperative day 3, they will receive half portion of normal diet and on postoperative day 4 normal diet.
Interventions
Enteral nutrition via nasojejunal tube
Eligibility Criteria
You may qualify if:
- Patient scheduled for elective open pancreatoduodenectomy.
- Patient ≥18 years old.
- Patient at nutritional risk, i.e., with Nutrition Risk Screening (NRS) ≥3.
- Signed informed consent.
You may not qualify if:
- Patient not able to give informed consent as documented by signature of consent form (e.g., vulnerable patients).
- Enteral feeding already initiated preoperatively.
- Language barrier.
- Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders (i.e., eating disorders and bipolar disorders), or dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hôpital Cochin-Port Royal, AP-HP
Paris, France
Lausanne University Hospital (CHUV)
Lausanne, Canton of Vaud, Switzerland
Regional Hospital of Lugano
Lugano, Canton Ticino, Switzerland
Related Publications (1)
Joliat GR, Martin D, Labgaa I, Melloul E, Uldry E, Halkic N, Fotsing G, Cristaudi A, Majno-Hurst P, Vrochides D, Demartines N, Schafer M. Early enteral vs. oral nutrition after Whipple procedure: Study protocol for a multicentric randomized controlled trial (NUTRIWHI trial). Front Oncol. 2022 Jun 28;12:855784. doi: 10.3389/fonc.2022.855784. eCollection 2022.
PMID: 35865476DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaëtan-Romain Joliat, MD
University of Lausanne Hospitals
- STUDY DIRECTOR
Markus Schäfer, MD
University of Lausanne Hospitals
- STUDY CHAIR
Nicolas Demartines, MD
University of Lausanne Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 30, 2021
First Posted
September 13, 2021
Study Start
December 12, 2021
Primary Completion
January 13, 2025
Study Completion
January 13, 2025
Last Updated
April 3, 2025
Record last verified: 2025-03